Carol O'Brien Selected Research

Carol O'Brien Research Topics

Disease

13	Breast Neoplasms (Breast Cancer) 01/2020 - 07/2008
13	Neoplasms (Cancer) 01/2020 - 07/2008
2	Schizophrenia (Dementia Praecox) 06/2014 - 04/2012
2	Lung Neoplasms (Lung Cancer) 12/2012 - 12/2011
2	Melanoma (Melanoma, Malignant) 12/2011 - 04/2009
1	Bites and Stings (Sting) 12/2022
1	COVID-19 01/2021
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2012
1	Alzheimer Disease (Alzheimer's Disease) 04/2012
1	Temporal Lobe Epilepsy 04/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2011
1	Colorectal Neoplasms (Colorectal Cancer) 08/2009
1	Genomic Instability 04/2009
1	Carcinogenesis 04/2009

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 01/2020 - 07/2008
5	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020 - 04/2009
4	Phosphotransferases (Kinase)IBA 03/2016 - 12/2008
4	Phenobarbital (Luminal)FDA Link 01/2016 - 07/2008
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2012 - 04/2009
3	Estrogen ReceptorsIBA 01/2020 - 08/2009
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 05/2012 - 04/2009
2	2- (3- (2- (1- isopropyl- 3- methyl- 1H- 1,2- 4- triazol- 5- yl)- 5,6- dihydrobenzo(f)imidazo(1,2- d)(1,4)oxazepin- 9- yl)- 1H- pyrazol- 1- yl)- 2- methylpropanamideIBA 01/2020 - 03/2016
2	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 03/2016 - 07/2010
2	MicroRNAs (MicroRNA)IBA 06/2014 - 06/2011
2	Class I Phosphatidylinositol 3-KinasesIBA 01/2014 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 05/2012 - 12/2008
2	MitogensIBA 05/2012 - 06/2011
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2011 - 04/2009
2	TensinsIBA 12/2011 - 04/2009
1	VenomsIBA 12/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2017
1	Aromatase (CYP19)IBA 03/2016
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 03/2016
1	Hormones (Hormone)IBA 03/2016
1	Letrozole (Femara)FDA LinkGeneric 03/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	Trastuzumab (Herceptin)FDA Link 05/2015
1	Formaldehyde (Formol)FDA Link 01/2014
1	ParaffinIBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2012
1	1- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA 12/2011
1	MTOR InhibitorsIBA 12/2011
1	TOR Serine-Threonine KinasesIBA 12/2011
1	ErbB Receptors (EGF Receptor)IBA 06/2011
1	Protein Kinases (Protein Kinase)IBA 06/2011
1	Transcription Factors (Transcription Factor)IBA 06/2011
1	Estrogen Receptor Modulators (Antiestrogen)IBA 08/2009
1	Monoclonal AntibodiesIBA 08/2009
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 08/2009
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 04/2009
1	2- (4- (1- (hydroxyimino)- 2,3- dihydro- 1H- inden- 5- yl)- 3- (pyridin- 4- yl)- 1H- pyrazol- 1- yl)ethan- 1- olIBA 04/2009
1	Mitogen-Activated Protein KinasesIBA 04/2009
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 04/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2008
1	Antimitotic AgentsIBA 07/2008
1	taxaneIBA 07/2008
1	monomethyl auristatin EIBA 07/2008

Therapy/Procedure

4	Therapeutics 03/2016 - 07/2009
1	Adjuvant Chemotherapy 01/2016